Urban Mental Health 2022: Overcoming Addiction in the Age of Fentanyl

Thursday, November 3, 2022, 9:00 AM - 3:00 PM, Rutgers NJMS, 185 South Orange Avenue, MSB B-552, Newark, NJ

1. Describe the neurobiological understanding of substance use disorders in 2022
2. Explain the pharmacology of medications for opioid use disorder
3. Provide rationale for buprenorphine as the superior choice in treatment for opioid use disorder in the age of fentanyl
4. Explore strategies to approach the treatment of co-occurring mental health and substance use disorders
5. Recommend how to speak with patients about aberrant drug screening results
6. Brainstorm strategies for achieving and maintaining recovery in those with SUD

General Registration Fee + CE Certificate:  $100 

Full-time students, interns, residents, and fellows may register for a reduced fee of $50. Registration should be accompanied by a program director’s letter confirming the full-time trainee status; please scan and email the letter to [email protected] 

 Registration for this course will close on 10/31/22 at 12 pm. The last day for cancellation refunds is 10/31/22.  If you would like to be added to the registration after this time please contact: UBHC Center for Continuing Education (CCE).

For participants who would like to receive an x-waiver to prescribe buprenorphine, please visit the Provider Clinical Support System Website to sign-up* for the waiver training and enter code: WAIVER-111748-10998.  

*The link will direct you to the main login page. If you don’t have an account, you will need to create one first and then click on the provided link to access the waiver training sign-up page. Please email Lisette Nazario or Clement Chen with any issues/questions.

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Nurses: This activity is awarded 4.5 contact hours (60 min CH). 

Physicians:  Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™.

Pharmacists:The knowledge-based activity qualifies for 4.5 contact hours of continuing pharmacy education credit. # UAN JA 0000855-0000-22-027-L01-P

Social Workers (The New Jersey Board of Social Work Examiners):  This program is approved for social work continuing education hours by Rutgers University Behavioral Health Care in accordance with New Jersey administrative code 13:44G-6.4 and recognized by The New Jersey Board of Social Work Examiners.  This program is approved for 4.5 clinical continuing education hours.

Psychologists: Rutgers University Behavioral Health Care and RBHS is approved by the American Psychological Association to sponsor continuing education for psychologists. Rutgers University Behavioral Health Care and RBHS maintains responsibility for the program and its content. (4.5 CE Credits).  

Certified Counselors:  Rutgers University Behavioral Health Care has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6198.  Programs that do not qualify for NBCC credit are clearly identified.  Rutgers University Behavioral Health Care is solely responsible for all aspects of the program. (4.5 Clock Hours)

Certified Alcohol and Drug Counselors: This course will count for 4.5 recertification credits for Addiction Professionals as approved by The Certification Board of NJ, Inc. Approval number for this course is # 

Certified Recovery Support Practitioner: This course will count for 4.5 recertification credits towards Certified Recovery Support Practitioner as approved by the Certification Board of NJ, Inc. Approval number for this course is # 

Marriage and Family Therapists: This course will count for 4.5 recertification credits for Marriage and Family Therapists as approved by The Certification Board of NJ, Inc. Approval number for this course is # 

Peer Review Statement
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, RBHS has resolved all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers. This activity was peer-reviewed for relevance, accuracy of content, and balance of presentation by: Stephanie Marcello PhD, and Laura Burns, LCSW, Rutgers University Behavioral Health Care.

Disclosure: In accordance with the disclosure policies of Rutgers and to conform with Joint Accreditation requirements and FDA guidelines, individuals in a position to control the content of this education activity are required to disclose to the activity participants: the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 24 months; and the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device that is not yet approved.

Faculty
The following faculty have no relevant financial relationships to disclosure:

Petros Levounis, MD, MA; Clement Chen, PharmD, BCPS; Emily Buirkle, MD; Saatchi Patell, MD; Hojun "Phillip" Yoo, MD; Kimberly Sue, MD, PhD; Jenna Mellor, MPA, BA; and Alexis LaPietra, DO, FACEP 

Peer Reviewers
Laura Burns, LCSW; Stephanie Marcello, PhD; Michele Miller, MSN, RN; Therese Saulo Reseska, LPC, LCADC; Richa Shah, PharmD;      have no relevant financial relationships to disclose.

Planners
The following planners have no relevant financial relationships to disclose:
Petros Levounis, MD, MA; Clement Chen, PharmD, BCPS; and Lisette Nazario, CPLC

Off-Label/Investigational Use Disclosure: Faculty are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation. These disclosures will be made to the audience at the time of the activity.

Content Disclaimer: The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, Rutgers University RBHS and New Jersey Medical School (NJMS).

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products or procedures before using them in clinical practice.

Copyright © 2022. Rutgers Biomedical and Health Sciences, UBHC and NJMS. All rights reserved including translation into other languages. No part of these activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval systems, without written permission from RBHS, UBHC, and NJMS.

Questions: Please direct content, CE-related or technical questions or concerns to Rutgers UBHC (CCE) by email at [email protected].

 

 

AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance (4.50 hours), ACPE Credits (4.50 hours), ANCC Contact Hours (4.50 hours), General Attendance (4.50 hours), CRSP Recertification Credits (4.50 hours), CADC Recertification Credits (4.50 hours), LPC/LAC: NBCC CE Clock Hours (4.50 hours), Social Worker: NJBSWE CE Credits (4.50 hours), NJDCA-MFT Recertification Credits (4.50 hours), Psychologist: APA CE Credits (4.50 hours)

No faculty are available for this activity at this time.

Rutgers Health UBHC has received no commercial support for this activity.